What You Should Know:

您应该知道：

–

–

Siemens Healthineers,

西门子Healthineers，

a leading global medical technology company operating in over 180 countries, is pioneering breakthroughs in healthcare through innovation and sustainability. With approximately 71,000 employees, Siemens Healthineers generated €21.7 billion in revenue in fiscal 2023.

一家在180多个国家运营的领先的全球医疗技术公司，正在通过创新和可持续性在医疗保健领域取得突破。西门子Healthineers拥有约71000名员工，在2023财年实现收入217亿欧元。

–       The company focuses on imaging, diagnostics, cancer care, and minimally invasive therapies, enhanced by advanced digital technology and artificial intelligence. Its mission includes improving access to healthcare for underserved communities and addressing the world’s most pressing diseases.

–该公司专注于成像、诊断、癌症护理和微创治疗，并通过先进的数字技术和人工智能得到增强。它的使命包括改善服务不足的社区获得医疗保健的机会，并解决世界上最紧迫的疾病。

Advancing Liver Healthcare: Siemens Healthineers and SimonMed Imaging Collaborate for Early Detection and Diagnosis

推进肝脏保健：西门子Healthineers和SimonMed Imaging合作进行早期发现和诊断

SimonMed Imaging, one of the largest outpatient medical imaging providers and radiology practices in the United States, has integrated multiple ACUSON Sequoia ultrasound systems from Siemens Healthineers. This collaboration aims to enhance liver disease diagnosis and early detection through cutting-edge imaging technology.

SimonMed Imaging是美国最大的门诊医学成像提供商和放射学实践之一，它集成了西门子Healthineers的多个ACUSON Sequoia超声波系统。这项合作旨在通过尖端成像技术增强肝病的诊断和早期发现。

The integration includes advanced liver imaging capabilities, such as Ultrasound Derived Fat Fraction (UDFF), across several SimonMed locations, including three sites in Arizona (Litchfield, Apache Junction, and Laveen) and two in Nevada (Centennial and Southwest)..

该集成包括先进的肝脏成像功能，例如超声衍生脂肪分数（UDFF），跨越几个SimonMed地点，包括亚利桑那州的三个地点（利奇菲尔德，阿帕奇交界处和拉文），以及内华达州的两个地点（百年和西南）。。

Key features of the ACUSON Sequoia ultrasound system include:

ACUSON Sequoia超声波系统的主要功能包括：

Comprehensive liver assessment through quantification of tissue stiffness and hepatic fat in a single acquisition.

通过在一次采集中定量组织硬度和肝脏脂肪进行全面的肝脏评估。

Streamlined patient care pathways and reduced need for invasive interventions.

。

Cost-effective screenings that improve accessibility and early detection.

具有成本效益的筛选，可提高可访问性和早期发现。

The adoption of UDFF technology addresses the challenge of asymptomatic liver disease progression, which can lead to conditions such as steatohepatitis, fibrosis, and cirrhosis. UDFF offers personalized, accurate, and noninvasive screening, delivering clinical utility comparable to MR-PDFF but as a more cost-effective alternative to MRI..

UDFF技术的采用解决了无症状肝病进展的挑战，这可能导致脂肪性肝炎，纤维化和肝硬化等疾病。。。

With over 100 million Americans affected by metabolic-associated steatotic liver disease (MASLD), the American Liver Foundation highlights the importance of early detection. MASLD, the leading cause of chronic liver disease, is often reversible when identified early. Despite its prevalence, fewer than 5% of affected individuals are aware of their condition.

美国肝脏基金会（American liver Foundation）强调了早期发现的重要性，有一亿多美国人受到代谢相关脂肪变性肝病（MASLD）的影响。MASLD是慢性肝病的主要原因，早期发现通常是可逆的。尽管患病率很高，但只有不到5%的受影响个体知道自己的病情。

The integration of Siemens Healthineers’ UDFF technology empowers clinicians with accessible tools for improved disease management and prevention of chronic liver disease..

西门子Healthineers的UDFF技术的集成为临床医生提供了可用的工具，以改进疾病管理和预防慢性肝病。。

“This collaboration represents a significant milestone in advancing liver healthcare through technological innovation,” said Travis Holles, head of the Americas for Siemens Healthineers Ultrasound business. SimonMed’s commitment to addressing the growing burden of liver disease underscores the potential of this partnership to transform patient outcomes by improving diagnostic accuracy and accessibility..

西门子Healthineers超声业务美洲区负责人特拉维斯·霍利斯（TravisHolles）表示：“此次合作是通过技术创新推进肝脏保健的一个重要里程碑。”。SimonMed致力于解决日益增长的肝病负担，这突显了这种伙伴关系通过提高诊断准确性和可及性来改变患者预后的潜力。。